Home
NewsNewsBirths resulting from essential Infertility Treatments, including advanced procedures like artificial insemination and IVF, have seen a very positive and promising climb, accounting for almost 15.1% of the total births recorded in 2024.
Two years ago, in 2024, one in seven newborns was born via infertility treatments like artificial insemination or in vitro fertilization – IVF as per a study in Korea. The proportion with regard to multiple births, including twins, has also seen a growth.
Confirms Study on Analysis of Side Effects of Infertility Treatments and Preparation of Management Plans from Health Insurance Review & Assessment Service, 36,025 out of 238,235 total births in 2024, which is about 15.1%, took place due to infertility treatments.
While the overall number of births saw a dip of 21.1% in a matter of five years, from 302,348 that were recorded in 2019 to 238,235 in 2024, rise in births with infertility treatments in Korea saw a jump of 36.6%, from 26,371 to 36,025. Notably, the proportion of births via infertility treatments almost doubled, rising from 8.7% to 15.1% between 2019 and 2024.
It is worth noting that the increase when it comes to infertility treatments has also gone on to raise the multiple birth rate. The size of multiple births across all the newborns grew from 4.6% in 2019 to 5.7% in 2024.
The rise in births with infertility treatments in Korea is due to the increasing age of marriage as well as childbirth, in addition to the health insurance coverage expansion when it comes to infertility treatments.
The proportion of multiple births in infants that were born by way of infertility treatments saw a slight dip from 35.5% in 2019 to 27.3% in 2024. But this does remain significantly higher as compared to the 1.6–1.8% rate for multiple births due to natural pregnancies. Apparently, the likelihood of multiple pregnancies increases when many embryos are transferred at the time of infertility treatment in order to enhance the success rates. The major dip when it comes to multiple births is attributed to the rising awareness of risks like maternal complications and also cerebral palsy in infants, thereby leading more parents to choose single-embryo transfers.
A professor of obstetrics and gynecology at the Seoul National University Hospital and also president of the Korean Maternal-Fetal Medicine Society, Park Jung-shin, said, “When undergoing infertility treatments, the various high-risk factors associated with multiple pregnancies must be thoroughly considered.”
A groundbreaking Nature Medicine study compares AI deep learning against expert embryologists in selecting embryos. While pregnancy rates remain comparable, the study uncovers a massive advantage in efficiency that could revolutionize IVF labs worldwide. Discover how AI-driven embryo selection accuracy is reshaping the future of fertility treatment.
FertilAI has received EU MDR clearance for tools advancing Predictive AI in Fertility through its Fertilane platform. StimAI and OvuPredict help clinicians optimise IVF timing, predict ovulation and improve scheduling efficiency. The technology supports scalable fertility care, reduced monitoring needs and better patient treatment experiences globally.
The Ferring Global Fertility Monitor has been launched by Ferring Pharmaceuticals and Gallup to examine fertility trends in 70 countries. Through large-scale surveys, the project will explore economic, social, and cultural influences on parenthood decisions. Insights are expected to guide policy, healthcare planning, and future demographic strategies.
Maven Clinic has expanded its Fertility and Family Building program with earlier diagnostics, wearable integration, and AI-powered personalised care. The enhanced platform supports faster diagnosis, improved treatment decisions, and condition-specific pathways for PCOS, endometriosis, and oncofertility. The rollout continues through 2026 with added innovations and partnerships.
Germany is debating the legalization of egg donation in Germany, challenging decades-old restrictions under the Embryo Protection Act. Experts argue reform is overdue to align with modern reproductive science, reduce fertility tourism, and improve patient care, while policymakers work to balance ethical concerns with growing demand for advanced fertility treatments.
A new review highlights the link from Forever Chemicals to reduced ART outcomes, showing how PFAS exposure impacts fertility, pregnancy, and reproductive health. The findings raise urgent concerns for IVF patients and call for stronger regulation, deeper research, and systemic action to address environmental risks in reproductive medicine.
The 2027 Title X NOFO introduces a major policy shift toward addressing infertility crisis in the U.S. It mandates basic infertility services, expands male reproductive health focus, and promotes education on body literacy and lifestyle factors, aiming to support family formation alongside traditional contraceptive services.
